Dialog Box

Loading...

Meningiomas are the most common type of brain tumours that develop from the meninges, which are the layers of tissue that cover the brain and the spinal cord in the central nervous system (CNS). These tumours are often benign (non-cancerous), however in rare cases they may become malignant (cancerous). Meningiomas are most commonly found in the cerebrum or cerebellum portions of the brain, but can develop anywhere in the CNS.

The brain is a complex organ that is responsible for controlling all functions of the body. It has five main portions: the cerebrum, cerebellum, brainstem, pituitary gland, and hypothalamus. The cerebrum is the biggest part of the brain, and consists of the frontal, parietal, temporal, and occipital lobes. This part of the brain is responsible for voluntary movement, intelligence, and memory. The cerebellum is a small part of the brain located at the back of the head, and regulates posture and balance. The brainstem is a small, stalk-like structure towards the bottom of the brain that connects the brain to the spinal cord.  It regulates many vital bodily processes, such as swallowing, breathing, and heart rate. The pituitary gland is a pea sized organ located behind the eyes, and is responsible for the production and secretion of hormones in the body. The hypothalamus is located deep within the brain, and has many important functions, such as producing and secreting different hormones, regulating temperature, and controlling appetite.

The spinal cord is a long, thin, tubular structure that extends down from the brainstem to the lower back. It is made of nerve tissue, and is surrounded by the bones of the spine (vertebrae). The spinal cord is responsible for transmitting nerve signals from the brain to the body, and vice versa. It has motor functions (such as voluntary movement), sensory functions (such as pressure, touch, temperature, and pain), and autonomous functions (such as regulating digestion, heart rate, and blood pressure).

Meningiomas are more common in women, and are generally diagnosed in people over the age of 60. However, anyone can develop this disease.

Types of Meningiomas

There are several types of meningiomas, which are often categorised by their location within the CNS, and their cellular appearance under the microscope.

Meningioma Subtypes Based on Location

Meningiomas can be classified by their location within the CNS.

Convexity Meningioma 

Convexity meningiomas are one of the most common subtypes of meningioma, and are generally found on the surface of the brain under the skull. It is found in an area known as the convexity, which connects the frontal and parietal lobes of the cerebrum. In many cases, convexity meningiomas are benign, and develop slowly over time.

Parasagittal/Falx Meningioma

Parasagittal meningiomas, also known as falx or falcine meningiomas, are tumours that develop in the falx cerebri, which is a sickle-shaped structure of dura mater (connective tissue that makes up part of the meninges). It is found between the two cerebral hemispheres of the brain. In many cases, parasagittal meningiomas are benign, and develop slowly over time.

Intraventricular Meningioma

Intraventricular meningiomas are a rare subtype of meningioma that often develops within the ventricles of the brain. The ventricles of the brain are large, open and complex structures that are responsible for the production and secretion of cerebrospinal fluid (CSF) in the body. In many cases, intraventricular meningiomas are benign, and develop slowly over time.

Skull Base Meningioma

Skull base meningiomas are a common subtype of meningioma that develop on the bones that form the base of the skull. These tumours are generally found beneath the brain and behind the eyes, and are often more difficult to surgically remove due to their location. In many cases, skull base meningiomas are benign, and develop slowly over time.

Sphenoid Wing Meningioma

Sphenoid wing meningioma is one of the most common types of meningioma, and is found on the sphenoid bone in the skull. The sphenoid bone is a wasp shaped structure that lies behind the top of the nasal cavity, and extends to the left and right side of the skull. In many cases, sphenoid wing meningiomas are benign, and develop slowly over time.

Olfactory Groove Meningioma

Olfactory groove meningiomas are a rare subtype of meningioma that develops in the nerves enabling our sense of smell. These nerves are partially contained in depressions of the ethmoid bone of the skull, known as olfactory grooves. In many cases, olfactory groove meningiomas are benign, and develop slowly over time.

Posterior Fossa/Petrous Meningioma

Posterior fossa meningiomas, also known as petrous meningiomas, are a rare subtype of meningioma that grow in the posterior fossa. This area of the brain is adjacent to the brainstem and cerebellum, and can cause problems with movement, hearing, and other important bodily functions. In some cases, this tumour can result in a condition called trigeminal neuralgia, which causes painful sensations (similar to an electric shock) on one side of the face. In many cases, posterior fossa meningiomas are benign, and develop slowly over time.

Suprasellar Meningioma

Suprasellar meningiomas are a rare subtype of meningioma that develops in the suprasellar regions of the brain. This area is near many important structures, such as the pituitary gland (gland primarily responsible for hormone secretion) and the optic nerve (nerves enabling our vision). In many cases, suprasellar meningiomas are benign, and develop slowly over time.

Meningioma Subtypes Based on Cellular Appearance

In addition to their location, meningiomas can also be classified by how the cancer cells look under the microscope.

Angiomatous Meningioma

Angiomatous meningiomas are a rare subtype of meningioma that are often classified as a benign or grade I tumour. These tumours are categorised by an abnormal abundance of blood vessels that make up over 50% of the tumour. These tumours are generally non-aggressive, slow growing, and can have a good prognosis.

Cystic Meningioma

Cystic meningiomas are a rare subtype of meningioma that are often classified as benign or grade I tumours. These tumours are categorised by the presence of a few, large cysts within the tumour, and are commonly confused with microcystic meningiomas. There are five classifications of cystic meningiomas, which are classified by location:

  • Type 1: cyst(s) are located centrally within the meningioma.
  • Type 2: cyst(s) are located within the meningioma, but not in the centre.
  • Type 3: cyst wall contains an area of tumour cells.
  • Type 4 (most common): cyst(s) are located in a separate portion of the brain adjacent to the meningioma.
  • Type 5 (arachnoid cyst): cyst is located between the meningioma and the adjacent brain.

Cystic meningiomas are generally non-aggressive, slow growing, and can have a good prognosis.

Fibroblastic Meningioma

Fibroblastic meningiomas, also known as fibrous meningiomas, are one of the most common types of meningioma that are often classified as a benign or grade I tumour. These tumours are categorised by spindle-shaped tumour cells, and are the most common variant of intraventricular meningiomas. These tumours are generally non-aggressive, slow growing, and can have a good prognosis.

Lymphoplasmacyte-rich Meningioma

Lymphoplasmacyte-rich meningiomas are a very rare subtype of meningioma that are often classified as benign or grade I tumours. These tumours are categorised by the presence of excess lymphocytes and plasma cells (types of white blood cells) within the tumour. Unlike most other types of meningiomas, lymphoplasmacytic-rich meningiomas are more common in children and young adults. These tumours are generally non-aggressive, slow growing, and can have a good prognosis.

Meningothelial Meningioma

Meningothelial meningioma, also known as syncytial or endothelial meningioma, is the most common type of meningioma that are often classified as a benign or grade I tumour. These tumours are categorised by the presence of syncytial cells, which are infected cells that have fused together with healthy cells resulting in an infected cell with multiple nuclei. These tumours are generally non-aggressive, slow growing, and can have a good prognosis.

Metaplastic Meningioma

Metaplastic meningioma is a very rare subtype of meningioma that is often classified as a benign or grade I tumour. There are several types of metaplastic meningiomas, including:

  • Cartilaginous meningiomas (tumour contains cells found in cartilage).
  • Lipomatous meningiomas (tumour contains cells found in adipose tissue/fat).
  • Melanotic meningiomas (tumour contains melanocytes, the cells responsible for providing pigment to our skin, hair, and eyes).
  • Myxoid meningiomas (tumour contains cells that produce mucus).
  • Osseous meningiomas (tumour contains cells found in bone).
  • Xanthomatous meningiomas (tumour contains cells with a lipid-filled vacuolated cytoplasm). 

These tumours are generally non-aggressive, slow growing, and can have a good prognosis.

Microcystic Meningioma

Microcystic meningiomas are a rare subtype of meningioma that is often classified as a benign or grade I tumour. These tumours are categorised by the presence of microscopic cysts scattered throughout the tumour, and may be confused with cystic meningiomas. These tumours are generally non-aggressive, slow growing, and can have a good prognosis.

Psammomatous Meningioma

Psammomatous meningiomas are a relatively common subtype of meningioma that is often classified as a benign or grade I tumour. These tumours are categorised by excess calcium build-up within the tumour, and are one of the most common meningiomas involving the spine. These tumours are generally non-aggressive, slow growing, and can have a good prognosis.

Secretory Meningioma

Secretory meningiomas are a rare subtype of meningioma that is often classified as a benign or a grade I tumour. These tumours are categorised by the presence of secretory globules (also known as pseudopsammoma bodies) that contain cytokeratin (a protein that helps form epithelial tissue, such hair, skin, and the lining of organs) and carcinoembryonic antigen (CEA) (a protein that acts as a tumour marker). These tumours are generally non-aggressive, slow growing, and can have a good prognosis.

Transitional Meningioma

Transitional meningiomas, also known as mixed meningiomas, is a relatively common type of meningioma that is often classified as a benign or a grade I tumour. These tumours are categorised by components of both meningothelial and fibroblastic (or fibrous) meningiomas. These tumours are generally non-aggressive, slow growing, and can have a good prognosis.

Atypical Meningioma 

Atypical meningiomas are a less common group of meningiomas that are often classified as a mid-grade or grade II tumour. These tumours show more cellular abnormality than grade I tumours, and tend to develop more rapidly. Atypical meningiomas are more likely to recur, and may not have as good of a prognosis as grade I tumours. There are two types of atypical meningiomas: 

  • Choroid meningiomas: a rare subtype categorised by meningioma cells developing within the choroid plexus. 
  • Clear cell meningiomas: a more common subtype categorised by ‘empty cells’, most notable in the spinal canal or posterior fossa. They tend to be more aggressive and have a higher recurrence rate than choroid meningiomas.

Anaplastic Meningioma 

Anaplastic meningiomas are a rare group of meningiomas that are often classified as high-grade or grade III tumours. These tumours show significant cellular abnormality and often develop quickly. Anaplastic meningiomas are generally much more aggressive than other subtypes, and may not have as good of a prognosis as grade I or II meningiomas. There are two types of anaplastic meningiomas:

  • Papillary meningiomas: a rare subtype categorised by perivascular pseudopapillary tumour cells. Unlike most meningiomas, these tumours generally affect patients around 40 years of age.
  • Rhabdoid meningiomas: a rare subtype characterised by the presence of rhabdoid cells within the tumour. This subtype is often very aggressive.

Treatment 

When cancers are detected, they are staged and graded based on size, metastasis (whether the cancer has spread to other parts of the body), and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, brain cancers are rarely staged, as they rarely spread to other parts of the body. Instead, they are generally graded from I-III. 

Meningiomas are generally graded by subtype: 

  • Grade 1 (benign) tumours: cancer cells present as slightly abnormal and are usually slow growing. Includes angiomatous meningiomas, cystic meningiomas, fibroblastic meningiomas, Lymphoplasmacyte-rich meningiomas, meningothelial meningiomas, microcystic meningiomas, psammomatous meningiomas, secretory meningiomas, and transitional meningiomas.
  • Grade II (atypical) tumours: cancer cells present as abnormal and grow faster than grade-I tumours. Includes choroid meningiomas and clear cell meningiomas.
  • Grade III (anaplastic) tumours: cancer cells present as very abnormal and grow quickly. Includes papillary meningiomas and rhabdoid meningiomas. 

Once your tumour has been graded, your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.  

Treatment is dependent on several factors, including location, age, stage of disease and overall health. 

Treatment options for meningiomas may include: 

  • Surgery to remove as much of the tumour as possible.
  • Watch and wait (for low-grade meningiomas).
  • Radiation therapy.
  • Clinical trials.
  • Palliative care.

For more information on the treatment options, please refer to the Rare Cancers Australia treatment options page.  

Risk factors 

While the cause of meningiomas remain unknown, the following factors may increase the risk of you developing the disease:

A potential link between elevated female sex hormones and the development of meningiomas has also been identified, however more research would be required to confirm this.

Not everyone with these risk factors will develop the disease, and some people who have the disease may have none of these risk factors. See your general practitioner (GP) if you are concerned. 

Early symptoms 

Meningiomas may appear asymptomatic in the early stages of disease, and often vary based on location within the CNS. 

The general symptoms of a meningioma in the brain include:

  • Seizures.
  • Headaches, often worse in the morning.
  • Blurred vision.
  • Weakness in your arms and/or legs.
  • Numbness. 
  • Changes in vision, such as blurriness and double vision.
  • Personality changes.
  • Decreased cognition.
  • Lack of emotion and/or interest (apathy).
  • Difficulty with balance and/or coordination.
  • Involuntary eye movements.
  • Hearing loss and/or ringing in the ears.
  • Memory loss.
  • Loss of smell.
  • Hydrocephalus.

In rare instances, meningiomas can also develop in the spinal cord. Symptoms of a spinal cord meningioma may include:

  • Difficulties walking.
  • Leg weakness and/or numbness.
  • Difficulties with urination and/or bowel movements.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned. 

Diagnosis/diagnosing 

If your doctor suspects you have a meningioma, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment.

Physical examination

Your doctor will collect your overall medical history, as well as your current symptoms. Following this, they may examine your body to check for any abnormalities.

Neurological examination

A neurological examination assesses sensory and motor functions, and can generally be done in your GPs office. The doctor may check your vision, hearing, balance, coordination, strength and reflexes, depending on the signs and symptoms you have described. Any problem that is detected in this exam can help determine which portion of the CNS needs further investigation.

Imaging & blood tests

The doctor will take images of your body using magnetic resonance imaging (MRI), a computed tomography scan (CT scan), x-rays, bone scan and/or positron emission tomography (PET scan), depending on where it is suspected the cancer is. The doctor may also look at other parts of the body and looks for signs of metastasis. Additionally, a blood test may be taken to assess your overall health and help guide treatment decisions.

Biopsy

Once the location of the cancer has been identified, the doctor will perform a biopsy to remove a section of tissue using a needle. This may be done during a surgery, or by a stereotactic needle biopsy.

Prognosis (Certain factors affect the prognosis and treatment options) 

While it is not possible to predict the exact course of the disease, your doctor may be able to give you a general idea based on the rate and depth of tumour growth, susceptibility to treatment, age, overall fitness, and medical history. Generally, low-grade meningiomas have a better prognosis and survival rates. However, if the cancer is advanced and has spread, the prognosis may not be as good and there may be a higher risk of cancer recurrence. It is very important to discuss your individual circumstances with your doctor to better understand your prognosis.

References 

Some references are to overseas websites. There may be references to drugs and clinical trials that are not available here in Australia.